Author

S. Gera

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell signaling & trafficking· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. Lizneva· 2 shared M. Zaidi· 2 shared S.-M. Kim· 2 shared T. Yuen· 2 shared A. A. Gumerova· 1 shared A. Gumerova· 1 shared A. Macdonald· 1 shared A. Padilla· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

D. Lizneva

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A Single Multipurpose FSH-Blocking Therapeutic for Osteoporosis and Obesity

S. Gera, T.-C. Kuo, F. Korkmaz, D. Sant, V. DeMambro, A. A. Gumerova, K. Sudha, A. Padilla, G. Prevot, J. Munitz, A. Teunissen, M. M. T. van Leent, T. G. J. M. Post, J. C. Fernandes, J. Netto, , M. Zaidi

This paper develops and tests a first-in-class FSH-blocking antibody, MS-Hu6, showing efficacy in preventing obesity and osteoporosis in mice and safety in monkeys.

bioRxiv · Feb 28, 2022 · PreprintPharmacology & Toxicology

The Hepcidin Regulator Erythroferrone is a New Member of the Erythropoiesis-Iron-Bone Circuitry

M. Castro-Mollo, S. Gera, M. Ruiz Martinez, M. Feola, A. Gumerova, M. Planoutene, C. Clementelli, V. Sangkhae, C. Casu, S.-M. Kim, V. Ostland, H. Han, E. Nemeth, R. Fleming, S. Rivella, , Y. Ginzburg

This study identifies erythroferrone as a regulator of the erythropoiesis-iron-bone circuitry, showing its role in modulating BMP signaling and preventing bone loss during erythropoiesis.

bioRxiv · Apr 9, 2021Physiology

Follicle stimulating hormone is an autocrine regulator of the ovarian cancer metastatic niche through Notch signaling

S. Gera, S. Kumar S, S. N. Swamy, R. Bhagat, A. Vadaparty, R. Gawari, R. Bhat, R. R. Dighe

This study shows that FSH regulates ovarian cancer metastasis via Notch signaling in spheroids, suggesting FSH and Notch as therapeutic targets.

bioRxiv · Dec 5, 2018Cancer Biology